These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 30930780)

  • 1. Actionable Pharmacogenetic Variation in the Slovenian Genomic Database.
    Hočevar K; Maver A; Peterlin B
    Front Pharmacol; 2019; 10():240. PubMed ID: 30930780
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacogenomic profile of actionable molecular variants related to drugs commonly used in anesthesia: WES analysis reveals new mutations.
    Parada-Márquez JF; Maldonado-Rodriguez ND; Triana-Fonseca P; Contreras-Bravo NC; Calderón-Ospina CA; Restrepo CM; Morel A; Ortega-Recalde OJ; Silgado-Guzmán DF; Angulo-Aguado M; Fonseca-Mendoza DJ
    Front Pharmacol; 2023; 14():1047854. PubMed ID: 37021041
    [No Abstract]   [Full Text] [Related]  

  • 3. Characterization of ADME Gene Variation in Colombian Population by Exome Sequencing.
    Silgado-Guzmán DF; Angulo-Aguado M; Morel A; Niño-Orrego MJ; Ruiz-Torres DA; Contreras Bravo NC; Restrepo CM; Ortega-Recalde O; Fonseca-Mendoza DJ
    Front Pharmacol; 2022; 13():931531. PubMed ID: 35846994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of computational predictions of the functional effect of idiosyncratic pharmacogenetic variants.
    McConnell H; Andrews TD; Field MA
    PeerJ; 2021; 9():e11774. PubMed ID: 34316407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Actionable pharmacogenetic variants in Hong Kong Chinese exome sequencing data and projected prescription impact in the Hong Kong population.
    Yu MHC; Chan MCY; Chung CCY; Li AWT; Yip CYW; Mak CCY; Chau JFT; Lee M; Fung JLF; Tsang MHY; Chan JCK; Wong WHS; Yang J; Chui WCM; Chung PHY; Yang W; Lee SL; Chan GCF; Tam PKH; Lau YL; Tang CSM; Yeung KS; Chung BHY
    PLoS Genet; 2021 Feb; 17(2):e1009323. PubMed ID: 33600428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of pharmacogenetic variants from large scale next generation sequencing data in the Saudi population.
    Goljan E; Abouelhoda M; ElKalioby MM; Jabaan A; Alghithi N; Meyer BF; Monies D
    PLoS One; 2022; 17(1):e0263137. PubMed ID: 35089958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variation in Actionable Pharmacogenetic Markers in Natives and Mestizos From Mexico.
    Gonzalez-Covarrubias V; Morales-Franco M; Cruz-Correa OF; Martínez-Hernández A; García-Ortíz H; Barajas-Olmos F; Genis-Mendoza AD; Martínez-Magaña JJ; Nicolini H; Orozco L; Soberón X
    Front Pharmacol; 2019; 10():1169. PubMed ID: 31649539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrating rare genetic variants into pharmacogenetic drug response predictions.
    Ingelman-Sundberg M; Mkrtchian S; Zhou Y; Lauschke VM
    Hum Genomics; 2018 May; 12(1):26. PubMed ID: 29793534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation in 100 relevant pharmacogenes among emiratis with insights from understudied populations.
    Al-Mahayri ZN; Patrinos GP; Wattanapokayakit S; Iemwimangsa N; Fukunaga K; Mushiroda T; Chantratita W; Ali BR
    Sci Rep; 2020 Dec; 10(1):21310. PubMed ID: 33277594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Prevalence of Pharmacogenomics Variants and Their Clinical Relevance Among the Pakistani Population.
    Khan AR; Shah SH; Ajaz S; Firasat S; Abid A; Raza A
    Evol Bioinform Online; 2022; 18():11769343221095834. PubMed ID: 35497687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene-Wise Burden of Coding Variants Correlates to Noncoding Pharmacogenetic Risk Variants.
    Park J; Lee SY; Baik SY; Park CH; Yoon JH; Ryu BY; Kim JH
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32349395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-Exome Sequencing Uncovers Novel Causative Variants and Additional Findings in Three Patients Affected by Glycogen Storage Disease Type VI and Fanconi-Bickel Syndrome.
    Eghbali M; Fatemi KS; Salehpour S; Abiri M; Saei H; Talebi S; Olyaei NA; Yassaee VR; Modarressi MH
    Front Genet; 2020; 11():601566. PubMed ID: 33505429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Requirements for comprehensive pharmacogenetic genotyping platforms.
    Lauschke VM; Ingelman-Sundberg M
    Pharmacogenomics; 2016 Jun; 17(8):917-24. PubMed ID: 27248710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational Tools to Assess the Functional Consequences of Rare and Noncoding Pharmacogenetic Variability.
    Zhou Y; Lauschke VM
    Clin Pharmacol Ther; 2021 Sep; 110(3):626-636. PubMed ID: 33998671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenomics in the era of next generation sequencing - from byte to bedside.
    Russell LE; Zhou Y; Almousa AA; Sodhi JK; Nwabufo CK; Lauschke VM
    Drug Metab Rev; 2021 May; 53(2):253-278. PubMed ID: 33820459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Projected Prevalence of Actionable Pharmacogenetic Variants and Level A Drugs Prescribed Among US Veterans Health Administration Pharmacy Users.
    Chanfreau-Coffinier C; Hull LE; Lynch JA; DuVall SL; Damrauer SM; Cunningham FE; Voight BF; Matheny ME; Oslin DW; Icardi MS; Tuteja S
    JAMA Netw Open; 2019 Jun; 2(6):e195345. PubMed ID: 31173123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational Methods for the Pharmacogenetic Interpretation of Next Generation Sequencing Data.
    Zhou Y; Fujikura K; Mkrtchian S; Lauschke VM
    Front Pharmacol; 2018; 9():1437. PubMed ID: 30564131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Next-Generation Sequencing in Pharmacogenetics and Pharmacogenomics.
    Schwarz UI; Gulilat M; Kim RB
    Cold Spring Harb Perspect Med; 2019 Feb; 9(2):. PubMed ID: 29844222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenomic incidental findings in 308 families: The NIH Undiagnosed Diseases Program experience.
    Lee EM; Xu K; Mosbrook E; Links A; Guzman J; Adams DR; Flynn E; Valkanas E; Toro C; Tifft CJ; Boerkoel CF; Gahl WA; Sincan M
    Genet Med; 2016 Dec; 18(12):1303-1307. PubMed ID: 27253732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of the implementation of a pharmacogenomics platform based on NGS technologies. Combining clinical and research approaches.
    Ramudo-Cela L; Busto-Fernández F; Outeda-Macías M; Antolín S; Calvo-Martínez L; Martín-Herranz I
    Farm Hosp; 2021 Dec; 45(7):11-37. PubMed ID: 35379108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.